Wrap up: Topical drug to prevent and treat New World screwworm in cattle receives conditionally approval, and other news

Good morning and happy Friday dvm360 readers! Our final Fetch conference of 2025, Fetch Long Beach is kicking off today. We hope all speakers, attendees, and exhibitors have a week full of fun, learning, networking, and more! Can’t make it to this year’s Fetch Long Beach? Don’t worry we kick off our Fetch conferences for 2026 in March with Fetch Charlotte, and registration is open for that!

However, if you wanted to get CE to end your year and can’t make Fetch Long Beach, dvm360’s first Fetch Encore is kicking off on December 14, 2025! Join dvm360 and veterinary leaders for a day full of feline fun! You can learn more about the virtual event, including where to register, here today!

For in between sessions at Fetch Long Beach, or to just catch up on the news from the week, here is what dvm360 covered this week:

• Fluralaner topical solution (Exzolt Cattle-CA1; Intervet Inc.) received conditional approval from the FDA for prevention and treatment of New World screwwormlarval infestations as well as treating and controlling cattle fever tick in beef cattle over 2 months of age, and replacement dairy heifers less than 20 months old.
• Veterinary professionals in Thailand made history earlier this month by performing the countries first successful pacemaker implantation in a feline patient after Pepsi, an 8-year-old domestic shorthair cat, suffered from severe cardiac arrythmia that caused her to have frequent fainting spells.
• On this week’s episode of The Vet Blast Podcast presented by dvm360, our host Adam Christman, DVM, MBA, sat down with Hunter Finn, DVM, and Noga Schiller, DVM, to take a deep dive in vaccine tittering, including advantages of in-house tests, how it can create personalized vaccination decisions, enhance pet care, and more.
• Are you heading to Fetch Long Beach this weekend, but don’t know where to start with picking out which lectures to go to? Don’t worry, dvm360 has your back.Check out these 5 sessions our editors are excited about this weekend!
• Serenity Vet, a veterinary relief management platform, officially launched a new subscription service that allows clinics and hospitals to manage relief veterinary staffing by seeing their availability in real time as well as scheduling, booking, and compensation payments.
• In other FDA news, the agency issued a draft guidance identify specific types of monoclonal antibody products it believes 6-month toxicity resting in nonhuman primates can be reduced or eliminated. This draft guidance is part of the FDA’s work to modernize nonclinical evaluation and reduce animal testing.
• And more!